US · Healthcare · Medical Care Facilities
EPS came in at 6.12 against a street estimate of 4.08 — a beat of 50.0%.
Analysts rate Tenet Healthcare Corporation a buy (19 buy, 4 hold, 0 sell out of 23) with an average price target of $285.32.
| Fund | Stake |
|---|---|
| BlackRock Inc | 10.86% |
| T. Rowe Price Associates, Inc. | 9.88% |
| Boston Partners Global Investors, Inc | 5.51% |
| Vanguard Portfolio Management, LLC | 5.26% |
| FMR Inc | 4.96% |
| Vanguard Capital Management, LLC | 4.84% |
| State Street Corp | 3.42% |
| Glenview Capital Management LLC | 2.78% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 TENET HEALTHCARE CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Company issued $2,000,000,000 in aggregate principal amount of 6.250% senior notes due | 2026-09-22 |
| Reg FD disclosure · Q3 2026 TENET HEALTHCARE CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Company issuing $2.0 billion in 6.250% senior notes due 2034 • Notes priced on Se | 2026-09-08 |
| Quarterly report · Q2 2026 TENET HEALTHCARE CORPORATION – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net operating revenues (6M 2026): $10,996 million vs. $10,494 million (6M 202 | 2026-07-29 |
| Results announced · Q3 2026 TENET HEALTHCARE CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net income available to common shareholders in Q2 2026: $826 million, or | 2026-07-23 |
| Shareholder vote results · Q2 2026 TENET HEALTHCARE CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held May 27, 2026 • All 12 director candidates elected | 2026-05-29 |
| Quarterly report · Q1 2026 TENET HEALTHCARE CORPORATION - Q1 2026 SUMMARY HEADLINE NUMBERS • Net operating revenues: $5,368 million (Q1 2026) vs. $5,223 million (Q1 2025) - up | 2026-04-30 |
| Results announced · Q2 2026 TENET HEALTHCARE CORPORATION – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net income available to common shareholders: $702 million ($8.01 per dilu | 2026-04-30 |
| Proxy statement · Q2 2026 TENET HEALTHCARE CORPORATION – PROXY SUMMARY FOR RETAIL INVESTORS CEO COMPENSATION • Saum Sutaria, M.D., Chairman and CEO: Total 2025 compensation w | 2026-04-16 |
Readable in the app.
| Announcement | Date |
|---|---|
| Omnibus agreement with CommonSpirit Health regarding Conifer restructuring Tenet Healthcare announced on February 2, 2026, that its 2025 Adjusted EBITDA will reach the upper end of its $4.47-4.57 billion guidance range, indicating strong operational performance. Ad | 2026-02-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tenet Healthcare Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.